Zh Nevrol Psikhiatr Im S S Korsakova
January 2021
Objective: To compare the efficacy of Cellex and Cortexin in patients in the early recovery period of ischemic stroke (ERPIS) receiving basic therapy (BT).
Material And Methods: Forty patients were randomized into the cellex group (=20) and the cortexin group 2 (=20). Cellex was administered in a dose of 0.